Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, today announced that it has appointed Jason F. Gorel as its interim...

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, today announced that Danny Brannagan, its Chief Financial Officer, will...

Year-end net profit of $23.5 million or $0.91 per share which includes net income from the sale of the AquaGuard operations Revenue from continuing operations increased 45% to $19.6 million for...

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, will release its Q4 and year end Fiscal 2021 financial results on...

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, today announces that Dr. Myrna Francis is retiring as a member of the...

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2021 third quarter results for the period...

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, will release its Q3 Fiscal 2021 financial results on Monday, August 30,...

Purchase and sale agreement executed with simultaneous closing with TIDI Products, LLC as buyer The transaction materially improves Covalon's balance sheet to an estimated net cash position of...

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, announced today the results of the matters voted upon at its Fiscal...

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2021 second quarter results for the period ended